SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...

This story is part of the KXAN Data Hub, where numbers help tell the whole story. We’ve created several data-driven stories and databases on topics including weather and climate, politics, education, ...

Astria Therapeutics, Inc. acquired by BioCryst for $13 per share, with the deal set to finalize in 1Q26. Click here to read ...

Important Disclosure: The content provided does not consider your particular circumstances and does not constitute personal advice. Some of the products promoted are from our affiliate partners from ...